glp 1 agonist lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating eli lilly oral glp-1 Eli
Description
FOR U.S
10.1111/jdi.12877 [DOI] [PMC free article] [PubMed] [Google Scholar] 52.United States Food and Drug Administration Potential signals of serious risks
The 20 mg vial dosing guide covers the larger vial calculations for those planning longer protocols
Higher likelihood of adverse effects
Always consult your healthcare provider before starting any new treatment
